Benzodiazepine Utilization in Ischemic Stroke Survivors: Analyzing Initial Excess Supply and Longitudinal Trends
Despite a gradual decline in benzodiazepine initiation from 2013 to 2021, we noted excessive supplies in prescriptions post-acute ischemic stroke discharge, underscoring the need for improved policies.
Authors
- Shuo Sun (ORCID: https://orcid.org/0000-0002-4170-9388)
- Sebastien Haneuse (ORCID: https://orcid.org/0000-0003-4963-0655)
- Deborah Blacker (ORCID: https://orcid.org/0000-0001-6107-7376)
- Victor Lomachinsky (ORCID: https://orcid.org/0000-0002-2306-6673)
- Julianne D. Brooks (ORCID: https://orcid.org/0000-0002-7624-2423)
- Joseph P. Newhouse (ORCID: https://orcid.org/0000-0001-5837-3203)
- John Hsu
- Lidia M.V.R. Moura (ORCID: https://orcid.org/0000-0002-1191-1315)
- Maria A. Donahue (ORCID: https://orcid.org/0000-0002-5217-7794)
- Lee H. Schwamm (ORCID: https://orcid.org/0000-0003-0592-9145)
- Mary Price
Institutions
- National Bureau of Economic Research (US)
- Yale New Haven Hospital (US)
- Harvard University (US)
- John F. Kennedy University (US)
- Yale University (US)
- Massachusetts General Hospital (US)
- Cancer Research And Biostatistics (US)
- Dana-Farber/Harvard Cancer Center (US)
Publication Details
- Journal
- Stroke
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1161/strokeaha.124.047257
- Citations
- 9
- Primary Topic
- Stroke Rehabilitation and Recovery
- Type
- article
- Field-Weighted Citation Impact
- 2.25
Funders
- National Institutes of Health
- Agency for Healthcare Research and Quality